March 12, 2020 / 9:41 PM / 24 days ago

BRIEF-Amphastar Pharmaceuticals Reports Q4 Revenue Of $83.4 Mln

March 12 (Reuters) - Amphastar Pharmaceuticals Inc:

* AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS AND FULL YEAR ENDED DECEMBER 31, 2019

* Q4 GAAP LOSS PER SHARE $0.02

* Q4 REVENUE $83.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $81.8 MILLION

* Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.07

* Q4 EARNINGS PER SHARE ESTIMATE $0.07 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below